School of Materials Science and Engineering, South China University of Technology, Guangzhou 510641, P. R. China.
National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou 510006, P. R. China.
J Mater Chem B. 2021 Apr 28;9(16):3573-3583. doi: 10.1039/d1tb00063b.
The regenerative repair of large bone defects is a major problem in orthopedics and clinical medicine. The key problem is the lack of ability of existing bone graft materials to promote osteogenesis and angiogenesis. Previous studies have shown that the osteogenic or angiogenic abilities of these materials could be significantly improved by adding miRNA or small-molecule drugs to bone graft materials; however, the synergistic effect arising from this combination is not clear. Therefore, we proposed to construct a dual drug delivery system that could simultaneously achieve the co-encapsulation and co-delivery of miRNA and small-molecule drugs to explore the effect of a dual drug delivery system on bone repair. In this study, we constructed dual-sized pore structure calcium-silicon nanospheres (DPNPs) and achieved the co-encapsulation of miR-210, angiogenic gene drugs, and simvastatin (Siv), a small-molecule osteogenic drug, through metal-ion coordination and physical adsorption. In vitro and in vivo osteogenic and angiogenic experiments showed that the dual drug delivery system (Siv/DPNP/miR-210) exhibited better properties than those of the individual unloaded and single drug-loaded systems and could significantly accelerate the process of bone repair, which provides a novel strategy for the regeneration and repair of bone defects.
大骨缺损的再生修复是骨科和临床医学的重大问题。关键问题是现有的骨移植材料缺乏促进成骨和血管生成的能力。先前的研究表明,通过向骨移植材料中添加 miRNA 或小分子药物,可以显著提高这些材料的成骨或血管生成能力;然而,这种组合的协同作用尚不清楚。因此,我们提出构建一种双重药物递送系统,能够同时实现 miRNA 和小分子药物的共包封和共递送,以探讨双重药物递送系统对骨修复的影响。在本研究中,我们构建了双尺寸孔结构的钙硅纳米球(DPNPs),并通过金属离子配位和物理吸附实现了 miR-210、血管生成基因药物和小分子成骨药物辛伐他汀(Siv)的共包封。体外和体内成骨和血管生成实验表明,双重药物递送系统(Siv/DPNP/miR-210)的性能优于未加载和单药加载系统,能够显著加速骨修复过程,为骨缺损的再生和修复提供了一种新策略。